KRYS

Krystal Biotech
KRYS

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$4.79B
EV
$4.05B
Shares Outstanding
29.93M
Beta
0.75

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$215.20
P/E 2025E
24.51x
P/Revenue 2025E
10.56x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Krystal Biotech, Inc.

gainify
KRYS

Krystal Biotech, Inc.

KRYS

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystr...

Sector

Healthcare

Industry

Biotechnology

CEO

Krishnan, Krish

Employees

275

IPO Date

2017-09-20

Headquarters

2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania, 15203, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved